Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, June 26, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, June 23, 2023
[ 12:00 AM ] - United States, WOPRAI
Olivia Brayer Reiterated (ALNY) at Hold and Held Target at $200 on, Jun 23rd, 2023
Olivia Brayer of Cantor Fitzgerald, Reiterated "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold and Held Target at $200 on, Jun 23rd, 2023.
Olivia has made no other calls on ALNY in the last 4 months.
There are 13 other peers that have a rating on ALNY. Out of the 13 peers that are also analyzing ALNY, 3 agree with Olivia's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Hoang of "SMBC Nikko" Initiated at Hold and Held Target at $220 on, Wednesday, April 26th, 2023
- Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $210 on, Tuesday, April 4th, 2023
- Jessica Fung of "JP Morgan" Maintained at Hold with Decreased Target to $196 on, Friday, March 3rd, 2023
These are the ratings of the 10 analyists that currently disagree with Olivia
- Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $275 on, Wednesday, May 31st, 2023
- Kostas Biliouris of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $250 on, Friday, May 5th, 2023
- Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $240 on, Friday, May 5th, 2023
- Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $415 on, Thursday, April 27th, 2023
- William Pickering of "Bernstein" Initiated at Buy and Held Target at $243 on, Tuesday, March 21st, 2023
- Whitney Ijem of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $291 on, Friday, February 24th, 2023
- David Lebovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $265 on, Friday, February 24th, 2023
- Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $250 on, Friday, February 24th, 2023
- Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $249 on, Friday, February 24th, 2023
- Michael King of "EF Hutton" Reiterated at Strong Buy and Held Target at $304 on, Friday, February 24th, 2023
